Terms: = Leukemia AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
38 results:
1. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract] [Full Text] [Related]
2. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a ddx3x::MLLT10 fusion and an IGH deletion.
Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
[TBL] [Abstract] [Full Text] [Related]
3. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
Zhang J; Dai H; Huo L; Burks JK; McGrail DJ; Lin SY
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907220
[TBL] [Abstract] [Full Text] [Related]
4. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract] [Full Text] [Related]
5. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.
Burkhardt B; Michgehl U; Rohde J; Erdmann T; Berning P; Reutter K; Rohde M; Borkhardt A; Burmeister T; Dave S; Tzankov A; Dugas M; Sandmann S; Fend F; Finger J; Mueller S; Gökbuget N; Haferlach T; Kern W; Hartmann W; Klapper W; Oschlies I; Richter J; Kontny U; Lutz M; Maecker-Kolhoff B; Ott G; Rosenwald A; Siebert R; von Stackelberg A; Strahm B; Woessmann W; Zimmermann M; Zapukhlyak M; Grau M; Lenz G
Nat Commun; 2022 Jul; 13(1):3881. PubMed ID: 35794096
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA networks in FLT3-ITD acute myeloid leukemia.
Hoang DH; Zhao D; Branciamore S; Maestrini D; Rodriguez IR; Kuo YH; Rockne R; Khaled SK; Zhang B; Nguyen LXT; Marcucci G
Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2112482119. PubMed ID: 35412895
[TBL] [Abstract] [Full Text] [Related]
7. Mortality among medical radiation workers in the United States, 1965-2016.
Boice JD; Cohen SS; Mumma MT; Howard SC; Yoder RC; Dauer LT
Int J Radiat Biol; 2023; 99(2):183-207. PubMed ID: 34731066
[TBL] [Abstract] [Full Text] [Related]
8. ddx3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1.
Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY
FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682
[TBL] [Abstract] [Full Text] [Related]
9. The protein landscape of chronic lymphocytic leukemia.
Meier-Abt F; Lu J; Cannizzaro E; Pohly MF; Kummer S; Pfammatter S; Kunz L; Collins BC; Nadeu F; Lee KS; Xue P; Gwerder M; Roiss M; Hüllein J; Scheinost S; Dietrich S; Campo E; Huber W; Aebersold R; Zenz T
Blood; 2021 Dec; 138(24):2514-2525. PubMed ID: 34189564
[TBL] [Abstract] [Full Text] [Related]
10. Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.
Nguyen LXT; Zhang B; Hoang DH; Zhao D; Wang H; Wu H; Su YL; Dong H; Rodriguez-Rodriguez S; Armstrong B; Ghoda LY; Perrotti D; Pichiorri F; Chen J; Li L; Kortylewski M; Rockne RC; Kuo YH; Khaled S; Carlesso N; Marcucci G
Leukemia; 2021 Aug; 35(8):2285-2298. PubMed ID: 33589748
[TBL] [Abstract] [Full Text] [Related]
11. Failure of tofacitinib to achieve an objective response in a
Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
[TBL] [Abstract] [Full Text] [Related]
12. CD56-positive diffuse large B-cell lymphoma/leukemia with
Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
[TBL] [Abstract] [Full Text] [Related]
13. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract] [Full Text] [Related]
14. Discrimination of different cancer types clustering Raman spectra by a super paramagnetic stochastic network approach.
González-Solís JL
PLoS One; 2019; 14(3):e0213621. PubMed ID: 30861043
[TBL] [Abstract] [Full Text] [Related]
15. Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
Battipaglia G; Boumendil A; Labopin M; Ciceri F; Tischer J; Stelljes M; Ehninger G; Beelen D; Finke J; Van Lint MT; Eder M; Afanasyev B; Fanin R; Mohty M; Ruggeri A; Nagler A
Bone Marrow Transplant; 2019 Sep; 54(9):1499-1510. PubMed ID: 30718798
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Kim B; Lee H; Shin S; Lee ST; Choi JR
J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
[TBL] [Abstract] [Full Text] [Related]
17. EBV in T-/NK-Cell Tumorigenesis.
Kimura H
Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
[TBL] [Abstract] [Full Text] [Related]
18. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
[TBL] [Abstract] [Full Text] [Related]
19. Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Takahashi K; Hu B; Wang F; Yan Y; Kim E; Vitale C; Patel KP; Strati P; Gumbs C; Little L; Tippen S; Song X; Zhang J; Jain N; Thompson P; Garcia-Manero G; Kantarjian H; Estrov Z; Do KA; Keating M; Burger JA; Wierda WG; Futreal PA; Ferrajoli A
Blood; 2018 Apr; 131(16):1820-1832. PubMed ID: 29358183
[TBL] [Abstract] [Full Text] [Related]
20. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ
Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648
[TBL] [Abstract] [Full Text] [Related]
[Next]
